| Walgreens #18071 | |
| 729 Anderson Ave, Cliffside Park, New Jersey 07010 | |
| (201) 943-2225 |
| Name | Walgreens #18071 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 729 Anderson Ave, Cliffside Park, New Jersey 07010 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (201) 943-2225 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Probiodrug AG announced today the transfer of its experimental cyclin-dependent kinase 9 inhibitor program to AstraZeneca. The transaction includes the sale to AstraZeneca of a lead molecule and back-up compounds with the associated intellectual property. CDK9, which has been implicated in the transcriptional regulation of genes involved in proliferation and inflammation, is a promising target for the treatment of both cancer and inflammatory diseases.
Not getting enough sleep may increase the likelihood of forming false memories, according to research published in Psychological Science, a journal of the Association for Psychological Science.
Whatever the outcome of healthcare reform, this much is clear: Information technology will play a critical role in the improvement and delivery of patient outcomes. So, will government contractors — they already are. So, who's in the lead?
BioSphere Medical, Inc. – the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today reported financial results for the three and 12 months ended December 31, 2009.
Abbott (NYSE: ABT) today announced at the European Society of Cardiology Congress the widespread availability of its next-generation XIENCE PRIME(TM) Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.
› Verified 9 days ago
| NPI Number | 1033636717 |
| Organization Name | WALGREEN CO |
| Doing Business As | RITE AID |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 729 Anderson Ave, Cliffside Park, NJ 07010 |
| Phone Number | 201-943-2225 |
News Archive
Probiodrug AG announced today the transfer of its experimental cyclin-dependent kinase 9 inhibitor program to AstraZeneca. The transaction includes the sale to AstraZeneca of a lead molecule and back-up compounds with the associated intellectual property. CDK9, which has been implicated in the transcriptional regulation of genes involved in proliferation and inflammation, is a promising target for the treatment of both cancer and inflammatory diseases.
Not getting enough sleep may increase the likelihood of forming false memories, according to research published in Psychological Science, a journal of the Association for Psychological Science.
Whatever the outcome of healthcare reform, this much is clear: Information technology will play a critical role in the improvement and delivery of patient outcomes. So, will government contractors — they already are. So, who's in the lead?
BioSphere Medical, Inc. – the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today reported financial results for the three and 12 months ended December 31, 2009.
Abbott (NYSE: ABT) today announced at the European Society of Cardiology Congress the widespread availability of its next-generation XIENCE PRIME(TM) Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.
› Verified 9 days ago
| NPI Number | 1306360268 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #18071 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 729 Anderson Ave, Cliffside Park, NJ 07010 |
| Phone Number | 201-943-2225 |
News Archive
Probiodrug AG announced today the transfer of its experimental cyclin-dependent kinase 9 inhibitor program to AstraZeneca. The transaction includes the sale to AstraZeneca of a lead molecule and back-up compounds with the associated intellectual property. CDK9, which has been implicated in the transcriptional regulation of genes involved in proliferation and inflammation, is a promising target for the treatment of both cancer and inflammatory diseases.
Not getting enough sleep may increase the likelihood of forming false memories, according to research published in Psychological Science, a journal of the Association for Psychological Science.
Whatever the outcome of healthcare reform, this much is clear: Information technology will play a critical role in the improvement and delivery of patient outcomes. So, will government contractors — they already are. So, who's in the lead?
BioSphere Medical, Inc. – the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today reported financial results for the three and 12 months ended December 31, 2009.
Abbott (NYSE: ABT) today announced at the European Society of Cardiology Congress the widespread availability of its next-generation XIENCE PRIME(TM) Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.
› Verified 9 days ago
News Archive
Probiodrug AG announced today the transfer of its experimental cyclin-dependent kinase 9 inhibitor program to AstraZeneca. The transaction includes the sale to AstraZeneca of a lead molecule and back-up compounds with the associated intellectual property. CDK9, which has been implicated in the transcriptional regulation of genes involved in proliferation and inflammation, is a promising target for the treatment of both cancer and inflammatory diseases.
Not getting enough sleep may increase the likelihood of forming false memories, according to research published in Psychological Science, a journal of the Association for Psychological Science.
Whatever the outcome of healthcare reform, this much is clear: Information technology will play a critical role in the improvement and delivery of patient outcomes. So, will government contractors — they already are. So, who's in the lead?
BioSphere Medical, Inc. – the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today reported financial results for the three and 12 months ended December 31, 2009.
Abbott (NYSE: ABT) today announced at the European Society of Cardiology Congress the widespread availability of its next-generation XIENCE PRIME(TM) Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.
› Verified 9 days ago
Have Shoes Will Travel Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 724 Anderson Ave, Cliffside Park, New Jersey 07010 Phone: (201) 233-8684 | |
Nature Med Pharmacy Llc Type: Pharmacy Location: 518 Anderson Ave, Cliffside Park, New Jersey 07010 Phone: (201) 945-8006 | |
Real Sleep Solutions Nj Llc Type: Medicare Supplier Location: 543 Gorge Rd, Cliffside Park, New Jersey 07010 Phone: (201) 943-7090 | |
Walgreens #18071 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 729 Anderson Ave, Cliffside Park, New Jersey 07010 Phone: (201) 943-2225 |